课题基金 / 基金详情

Mobile element mutagenesis as a driver of human cancers

Mobile element mutagenesis as a driver of human cancers
移动元件突变是人类癌症的驱动因素
批准号:
10675557
负责人:
Scott E Devine
金额:
$34.64万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-02 至 2027-07-31

项目摘要

项目成果

Scott E Devine的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary. Human LINE-1 (L1) elements are autonomous retrotransposons that continue to produce new “offspring” L1 insertions in human genomes. Until recently, L1 elements were thought to be mobilized primarily in the germline and then silenced in somatic cells throughout adulthood. However, several recent reports have shown that L1 elements are active in at least some adult somatic tissues, including the brain and epithelial somatic tumors. These observations have led to the suggestion that L1 might play a role in initiating human cancers by mutating specific tumor suppressor genes and oncogenes in somatic cells. In the three aims of this proposal, we will further explore this hypothesis with an emphasis on studying the expression, regulation, and mobilization of the full-length L1 source elements that generate new L1 insertions. In Specific Aim 1, we will generate a comprehensive resource of full-length, human-specific L1 (FL-L1Hs) source elements that will be used throughout this proposal (Aims 1-3) to study the role of L1 mobilization in human tissues and tumors. In Specific Aim 2, we will examine the expression and regulation of FL-L1Hs elements that can evade somatic repression and will study the mechanism(s) whereby these elements manage to do this. Finally, in Specific Aim 3, we will examine the mobilization capacities of FL-L1Hs elements. Combined with the data generated in Aims 1 and 2, these data will allow us to better understand the expression, regulation, and mobilization of the FL-L1Hs elements that mutagenize the human genome. The successful completion of the three Aims of this study will transform our understanding of how mobile elements impact human diseases, including cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
L1 element mutagenesis as a driver of epithelial cancers in African Americans
  • 批准号:
    10350837
  • 项目类别:
  • 资助金额:
    $21.67万
  • 财政年份:
    2022
  • 负责人:
    Scott E Devine
  • 依托单位:
Mobile element mutagenesis as a driver of human cancers
  • 批准号:
    10517586
  • 项目类别:
  • 资助金额:
    $35.34万
  • 财政年份:
    2022
  • 负责人:
    Scott E Devine
  • 依托单位:
L1 element mutagenesis as a driver of epithelial cancers in African Americans
  • 批准号:
    10543470
  • 项目类别:
  • 资助金额:
    $17.7万
  • 财政年份:
    2022
  • 负责人:
    Scott E Devine
  • 依托单位:
Natural mutagenesis of human genomes by endogenous retrotransposons
  • 批准号:
    8460004
  • 项目类别:
  • 资助金额:
    $29.94万
  • 财政年份:
    2012
  • 负责人:
    Scott E Devine
  • 依托单位:
国内基金
海外基金
Sitagliptin通过microbiota-gut-brain轴在2型糖尿病致阿尔茨海默样变中的脑保护作用机制
  • 批准号:
    81801389
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    21.0万元
  • 批准年份:
    2018
  • 负责人:
    田茗源
  • 依托单位:
平扫描数据导引的超低剂量Brain-PCT成像新方法研究
  • 批准号:
    81101046
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2011
  • 负责人:
    黄静
  • 依托单位: